Anjali Mishra

Anjali Mishra, PhD is an active Assistant Professor in the Department of Medical Oncology within the College of Life Sciences, focusing on hematological malignancies. Her work bridges clinical oncology and molecular research to address unmet therapeutic needs in T-cell cancers.

Her research prioritizes Cutaneous T-cell Lymphoma, Leukemia, and DNA Damage Response mechanisms, with expertise in p53 pathway reactivation, apoptosis induction, and novel drug combinations. She investigates targets like CD38 and XPO1 to overcome treatment resistance in aggressive lymphomas.

Publication analysis reveals a cohesive trajectory: her work consistently dissects molecular drivers (e.g., p53 dysfunction in T-PLL) while exploring clinically viable interventions like subcutaneous alemtuzumab. Key themes include biomarker-driven therapy, clonal evolution in mycosis fungoides, and pathway-specific drug synergies.